These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1980473)

  • 1. The membrane stabilizing and beta 1-adrenoceptor blocking activity of (+)- and (-)-propranolol on the rat left atria.
    Doggrell SA
    Gen Pharmacol; 1990; 21(5):677-80. PubMed ID: 1980473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous assessment of membrane-stabilizing and beta-adrenoceptor blocking activity of drugs with the rat isolated left atria.
    Doggrell SA
    J Pharmacol Methods; 1988 Apr; 19(2):93-107. PubMed ID: 2896276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of (+/-)- (+)- and (-)-metoprolol, (+/-)- (+)- and (-)-pindolol, (+/-)-mepindolol and (+/-)-bopindolol on the rat left atria and portal vein.
    Doggrell SA
    Gen Pharmacol; 1991; 22(6):1169-77. PubMed ID: 1687398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the assessment of the beta-adrenoceptor blocking activity of propranolol using the rat isolated right ventricle.
    Doggrell SA; Hughes EW
    J Pharmacol Methods; 1986 Apr; 15(2):119-31. PubMed ID: 2871235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bromoacetylalprenololmenthane (BAAM), an irreversible beta-adrenoceptor antagonist, on the rat isolated left atria and portal vein.
    Doggrell SA
    J Auton Pharmacol; 1990 Dec; 10(6):333-44. PubMed ID: 1982668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsinolol: the first beta-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart.
    Chen IJ; Yeh JL; Lo YC; Sheu SH; Lin YT
    Br J Pharmacol; 1996 Sep; 119(1):7-14. PubMed ID: 8872350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by propranolol of the contractile response of the rat diaphragm to tetanic field stimulation in vitro.
    Drazen JM; Lacouture PG; Miller MJ
    Br J Pharmacol; 1983 Dec; 80(4):613-8. PubMed ID: 6571223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
    Whalen EJ; Bates JN; Johnson AK; Lewis SJ
    Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence against beta-adrenoceptor blocking activity of diltiazem, a drug with calcium antagonist properties.
    Briley M; Cavero I; Langer SZ; Roach AG
    Br J Pharmacol; 1980 Aug; 69(4):669-73. PubMed ID: 6108142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of (+)- and (-)-propranolol on 3H-transmitter efflux in guinea-pig atria and the presynaptic beta-adrenoceptor hypothesis.
    Kalsner S
    Br J Pharmacol; 1980 Nov; 70(3):491-8. PubMed ID: 6108147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.
    Juberg EN; Minneman KP; Abel PW
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):193-202. PubMed ID: 2865685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atenolol, bufuralol and prizidilol are dual antagonists of the responses of the electrically driven rat right ventricle strip to isoprenaline.
    Doggrell SA
    Gen Pharmacol; 1989; 20(6):839-42. PubMed ID: 2574123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alprenolol and bromoacetylalprenololmenthane are competitive slowly reversible antagonists at the beta 1-adrenoceptors of rat left atria.
    Surman AJ; Doggrell SA
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):35-9. PubMed ID: 7678677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of aortic banding-induced cardiac hypertrophy by propranolol is independent of beta-adrenoceptor blockade.
    Marano G; Palazzesi S; Fadda A; Vergari A; Ferrari AU
    J Hypertens; 2002 Apr; 20(4):763-9. PubMed ID: 11910314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.